Driehaus Capital Management’s iRadimed IRMD Stock Holding History

Driehaus Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-27,032	Closed	-$813K	–	375
2022 Q3	$813K	Sell	27,032 -37,189	-58%	-$1.3M	0.01%	309
2022 Q2	$2.18M	Buy	64,221 +12,148	+23%	+$435K	0.04%	295
2022 Q1	$2.33M	Buy	52,073 +10,073	+24%	+$466K	0.03%	316
2021 Q4	$1.94M	Buy	+42,000	New	+$1.69M	0.02%	304
2018 Q4	–	Sell	-70,153	Closed	-$2.61M	–	462
2018 Q3	$2.61M	Buy	+70,153	New	+$1.89M	0.08%	261
2016 Q1	–	Sell	-19,066	Closed	-$534K	–	593
2015 Q4	$534K	Buy	+19,066	New	+$539K	0.02%	453

Other funds holding IRMD

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

BCM

Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Driehaus Capital Management's IRMD Position: Q4 2022 in Review

Driehaus Capital Management sold out of iRadimed (IRMD) in Q4 2022, closing a stake of 27,032 shares — an estimated $813K sold.

Driehaus Capital Management first reported a position in IRMD in Q4 2015 and held it in 6 quarters. The position peaked at $2.61M in Q3 2018. 80 funds tracked by Wall St. Rank hold IRMD as of Q4 2022.

Driehaus Capital Management reported no remaining iRadimed position as of Q4 2022 after selling out during the quarter.
Driehaus Capital Management sold 27,032 iRadimed shares in Q4 2022, an estimated $813K.
Driehaus Capital Management first reported a position in iRadimed in Q4 2015 and held it in 6 quarters.
Driehaus Capital Management's iRadimed position peaked at $2.61M in Q3 2018.
80 funds tracked by Wall St. Rank held iRadimed as of Q4 2022.

Based on Driehaus Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.